Literature DB >> 843246

Progressive focal deficit with porencephaly.

W R Leahy, H S Singer.   

Abstract

The association of porencephalic cysts with hydrocephalus was first cited in 1939. Subsequent descriptions of this combination in terms of fixed, nonprogressive neurological problems have been reported. We describe four patients with hydrocephalus who had progressive focal motor deficits secondary to porencephalic diverticulation of the lateral ventricle. Symptoms of increased intracranial pressure were not a consistent finding in all patients. Enlargement of the porencephalic cyst is related to either a generalized increase in intraventricular pressure or to "hydrostatic" forces that may act independently. Computerized axial tomography has provided a noninvasive technique that allows definition of the abnormality and its progression. Neurosurgical intervention has resulted in clinical improvement in all patients studied.

Entities:  

Mesh:

Year:  1977        PMID: 843246     DOI: 10.1001/archneur.1977.00500150040007

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  4 in total

1.  Ventricular pseudodiverticula from intraparenchymal cerebrospinal fluid dissection secondary to high-grade obstructive hydrocephalus in children: magnetic resonance imaging findings.

Authors:  Sonia F Calloni; Bruno P Soares; Thierry Agm Huisman
Journal:  Neuroradiol J       Date:  2017-06-23

2.  Reversible porencephaly. Alteration of the cerebrospinal fluid flow after shunt malfunction.

Authors:  K Sugimoto; T Enomoto; T Nose
Journal:  Childs Nerv Syst       Date:  1991-11       Impact factor: 1.475

3.  The significance of morphological details for developmental outcome in infantile hydrocephalus.

Authors:  R W Oberbauer
Journal:  Childs Nerv Syst       Date:  1985       Impact factor: 1.475

4.  Traumatic porencephaly with strabismus: a case report.

Authors:  A H Sarmast; H I Showkat; S Farooq Mir; O Masood; A R Kirmani; A R Bhat
Journal:  Iran Red Crescent Med J       Date:  2012-07-30       Impact factor: 0.611

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.